STOCK TITAN

CHMI-PA Financials

CHMI-PA
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows CHMI-PA (CHMI-PA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CHMI-PA FY2025

Asset growth has been funded mainly by liabilities and fresh equity, while cash generation lags reported earnings and dividends.

From FY2022 to FY2025, total assets increased by $132M while equity fell by $26M and retained earnings became more negative, so the balance sheet expanded without building a larger owner cushion. That helps explain why dividends outpaced internally generated cash in FY2025, with $28.7M paid against $19.1M of operating cash flow.

Accounting profit and cash flow have not moved together: FY2024 posted $12.2M of net income but -$4.7M of operating cash flow. The next year reversed that pattern, which suggests period-to-period profit is shaped more by valuation or timing effects than by a steady stream of cash receipts.

The reported debt-to-equity ratio understates how liability-funded the business is, because FY2025 ended with $1.30B of total liabilities against only $236M of equity, a thin owner cushion for a balance sheet this large. Share count also kept rising, from 23.5M to 36.7M over the last three valid fiscal years, so the capital base was spread across many more claims.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 17 / 100
Financial Profile 17/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of CHMI-PA's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage
89

CHMI-PA carries a low D/E ratio of 0.62, meaning only $0.62 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 89/100, indicating a strong balance sheet with room for future borrowing.

Returns
12

CHMI-PA generates a 2.9% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 12/100. This is down from 5.3% the prior year.

Piotroski F-Score Neutral
4/9

CHMI-PA passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
2.75x

For every $1 of reported earnings, CHMI-PA generates $2.75 in operating cash flow ($19.1M OCF vs $6.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$23.3M
YoY-32.5%
10Y CAGR+37.6%

CHMI-PA generated $23.3M in revenue in fiscal year 2025. This represents a decrease of 32.5% from the prior year.

EBITDA
N/A
Net Income
$6.9M
YoY-43.1%
10Y CAGR-6.2%

CHMI-PA reported $6.9M in net income in fiscal year 2025. This represents a decrease of 43.1% from the prior year.

EPS (Diluted)
$-0.09
YoY-228.6%

CHMI-PA earned $-0.09 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 228.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$54.9M
YoY+18.6%
5Y CAGR-8.1%
10Y CAGR+17.9%

CHMI-PA held $54.9M in cash against $146.3M in long-term debt as of fiscal year 2025.

Dividends Per Share
$0.50
YoY-16.7%
5Y CAGR-16.2%
10Y CAGR-12.9%

CHMI-PA paid $0.50 per share in dividends in fiscal year 2025. This represents a decrease of 16.7% from the prior year.

Shares Outstanding
37M
YoY+16.2%
5Y CAGR+16.6%
10Y CAGR+17.2%

CHMI-PA had 37M shares outstanding in fiscal year 2025. This represents an increase of 16.2% from the prior year.

Margins & Returns

Gross Margin
60.2%
YoY-3.9pp

CHMI-PA's gross margin was 60.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 3.9 percentage points from the prior year.

Operating Margin
N/A
Net Margin
29.8%
YoY-5.5pp
10Y CAGR-1349.6pp

CHMI-PA's net profit margin was 29.8% in fiscal year 2025, showing the share of revenue converted to profit. This is down 5.5 percentage points from the prior year.

Return on Equity
2.9%
YoY-2.4pp
5Y CAGR+20.1pp
10Y CAGR-5.8pp

CHMI-PA's ROE was 2.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.4 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

CHMI-PA Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue $11.8M+37.2% $8.6M+42.0% $6.0M N/A $18.7M N/A $6.6M-59.8% $16.3M
Cost of Revenue $2.5M+8.0% $2.3M+17.7% $2.0M-23.3% $2.5M-18.5% $3.1M-2.6% $3.2M-7.2% $3.5M+31.2% $2.6M
Gross Profit $9.3M+47.9% $6.3M+53.6% $4.1M+173.0% -$5.6M-135.9% $15.6M+251.7% -$10.3M-429.2% $3.1M-77.2% $13.7M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $1.5M-28.3% $2.2M+10.6% $1.9M-5.4% $2.1M-17.9% $2.5M-22.5% $3.2M+1.1% $3.2M+86.2% $1.7M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $12.6M+2.3% $12.3M+1.4% $12.2M-3.7% $12.6M-12.2% $14.4M+1.2% $14.2M+5.2% $13.5M-1.0% $13.6M
Income Tax $619K+118.0% $284K-74.7% $1.1M+548.0% $173K-92.9% $2.5M+759.6% $285K-57.1% $664K-5.5% $703K
Net Income $7.9M+74.0% $4.5M+189.2% $1.6M+122.3% -$7.0M-159.2% $11.8M+194.9% -$12.4M-1687.2% $784K-93.5% $12.1M
EPS (Diluted) N/A $0.05+266.7% $-0.03+89.7% $-0.29 N/A $-0.49-716.7% $-0.06-118.8% $0.32

CHMI-PA Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $1.5B+1.3% $1.5B+2.1% $1.5B+2.8% $1.4B-2.8% $1.5B-3.9% $1.6B+9.5% $1.4B+0.8% $1.4B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $54.9M-0.9% $55.4M-4.5% $58.0M+22.7% $47.3M+2.1% $46.3M-7.7% $50.2M-4.3% $52.4M+10.3% $47.5M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $1.3B+1.2% $1.3B+2.2% $1.3B+3.1% $1.2B-3.0% $1.3B-4.1% $1.3B+11.3% $1.2B+2.0% $1.2B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt $146.3M-1.2% $148.0M-1.4% $150.1M0.0% $150.1M-1.3% $152.1M+0.2% $151.8M-5.4% $160.5M-4.2% $167.5M
Total Equity $236.0M+1.2% $233.1M+1.4% $229.9M+1.5% $226.6M-1.6% $230.3M-2.7% $236.7M+0.9% $234.5M-5.0% $247.0M
Retained Earnings -$270.4M+0.6% -$272.0M-0.6% -$270.2M-2.4% -$263.9M-5.7% -$249.6M+1.7% -$253.9M-8.3% -$234.4M-2.8% -$228.0M

CHMI-PA Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow $8.4M+449.5% -$2.4M-119.2% $12.5M+1725.7% $682K-88.5% $5.9M+35.8% $4.4M+7.5% $4.1M+121.3% -$19.1M
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow -$42.3M-70.2% -$24.8M-30.5% -$19.0M-197.7% $19.5M-26.3% $26.4M+127.2% -$96.9M-536.5% -$15.2M+72.6% -$55.5M
Financing Cash Flow $31.7M+32.9% $23.9M-5.5% $25.3M+160.7% -$41.6M-156.5% -$16.2M-118.3% $88.7M+423.3% $17.0M-70.8% $58.0M
Dividends Paid $6.2M-21.6% $7.9M+6.4% $7.4M+1.9% $7.2M-1.2% $7.3M+3.9% $7.1M+3.6% $6.8M-2.1% $7.0M
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

CHMI-PA Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin 78.9%+5.7pp 73.2%+5.5pp 67.7% N/A 83.3% N/A 47.5%-36.4pp 83.9%
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 66.8%+14.1pp 52.7%+26.8pp 25.9% N/A 63.1% N/A 11.9%-61.8pp 73.8%
Return on Equity 3.3%+1.4pp 1.9%+1.3pp 0.7%+3.8pp -3.1%-8.2pp 5.1%+10.4pp -5.3%-5.6pp 0.3%-4.6pp 4.9%
Return on Assets 0.5%+0.2pp 0.3%+0.2pp 0.1%+0.6pp -0.5%-1.3pp 0.8%+1.6pp -0.8%-0.9pp 0.1%-0.8pp 0.9%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 0.62-0.0 0.63-0.0 0.650.0 0.660.0 0.66+0.0 0.64-0.0 0.680.0 0.68
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Frequently Asked Questions

CHMI-PA (CHMI-PA) reported $23.3M in total revenue for fiscal year 2025. This represents a -32.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

CHMI-PA (CHMI-PA) revenue declined by 32.5% year-over-year, from $34.6M to $23.3M in fiscal year 2025.

Yes, CHMI-PA (CHMI-PA) reported a net income of $6.9M in fiscal year 2025, with a net profit margin of 29.8%.

CHMI-PA (CHMI-PA) reported diluted earnings per share of $-0.09 for fiscal year 2025. This represents a -228.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, CHMI-PA (CHMI-PA) had $54.9M in cash and equivalents against $146.3M in long-term debt.

CHMI-PA (CHMI-PA) had a gross margin of 60.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

CHMI-PA (CHMI-PA) had a net profit margin of 29.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, CHMI-PA (CHMI-PA) paid $0.50 per share in dividends during fiscal year 2025.

CHMI-PA (CHMI-PA) has a return on equity of 2.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

CHMI-PA (CHMI-PA) generated $19.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

CHMI-PA (CHMI-PA) had $1.5B in total assets as of fiscal year 2025, including both current and long-term assets.

CHMI-PA (CHMI-PA) had 37M shares outstanding as of fiscal year 2025.

CHMI-PA (CHMI-PA) had a debt-to-equity ratio of 0.62 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

CHMI-PA (CHMI-PA) had a return on assets of 0.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

CHMI-PA (CHMI-PA) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

CHMI-PA (CHMI-PA) has an earnings quality ratio of 2.75x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

CHMI-PA (CHMI-PA) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top